Anmol Ganjoo, pharma analyst, Antique Stock Broking says one should give the company time to fix the various problems in its US business and wait before taking a view unless one sees an improvement on ground.
first published: Jul 3, 2013 02:25 pm
A collection of the most-viewed Moneycontrol videos.

Market Braces For Tough Session Amid AI-Led Global Tech Rout | RBI Policy Today | Opening Bell Live

Live: Nifty slips below 25,650 amid broad-based selloff; IT continues freefall | Closing Bell

Can Nifty Power Ahead For Fourth Day Despite Anthropic-Led Tech Jitters? | Opening Bell Live

Investing for a new era | LIVE conversation with Mukesh Ambani & Larry Fink
You are already a Moneycontrol Pro user.